The liver enzymes, consisting of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), were suggested to have substantial clinical and convenient surrogate markers that reflect excess fat deposition in the liver and nonalcoholic fatty liver disease (NAFLD) and other related dysfunctions [12–14]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.